CD40 negatively regulates ATP-TLR4-activated inflammasome in microglia S Gaikwad, D Patel, R Agrawal-Rajput Cellular and molecular neurobiology 37, 351-359, 2017 | 42 | 2017 |
Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis D Patel, S Gaikwad, N Challagundla, M Nivsarkar, R Agrawal-Rajput International immunopharmacology 54, 375-384, 2018 | 39 | 2018 |
CGGBP1 regulates CTCF occupancy at repeats D Patel, M Patel, S Datta, U Singh Epigenetics & Chromatin 12, 1-22, 2019 | 10 | 2019 |
Dynamic bimodal changes in CpG and non-CpG methylation genome-wide upon CGGBP1 loss-of-function D Patel, M Patel, B Westermark, U Singh BMC research notes 11, 1-7, 2018 | 10 | 2018 |
Transposable elements as tissue-specific enhancers in cancers of endodermal lineage K Karttunen, D Patel, J Xia, L Fei, K Palin, L Aaltonen, B Sahu Nature Communications 14 (1), 5313, 2023 | 9 | 2023 |
Caspase-1 inhibition by YVAD generates tregs pivoting IL-17 to IL-22 response in β-glucan induced airway inflammation D Patel, N Challagundla, D Mandaliya, S Yadav, O Naik, P Dalai, D Shah, ... Immunopharmacology and Immunotoxicology, 1-10, 2022 | 5 | 2022 |
CGGBP1-regulated cytosine methylation at CTCF-binding motifs resists stochasticity M Patel, D Patel, S Datta, U Singh BMC genetics 21, 1-21, 2020 | 5 | 2020 |
CGGBP1-dependent CTCF-binding sites restrict ectopic transcription D Patel, M Patel, S Datta, U Singh Cell Cycle 20 (22), 2387-2401, 2021 | 4 | 2021 |
An immunochemistry-based screen for chemical inhibitors of DNA-protein interactions and its application to human CGGBP1 M Patel, D Patel, S Datta, U Singh BMC cancer 20, 1-14, 2020 | 1 | 2020 |
Distinct DNA sequence preference for histone occupancy in primary and transformed cells S Datta, M Patel, D Patel, U Singh Cancer Informatics 18, 1176935119843835, 2019 | 1 | 2019 |
G-quadruplex landscape and its regulation revealed by a new antibody capture method S Datta, M Patel, C Sathyaseelan, C Ghosh, A Mudgal, D Patel, ... Oncotarget 15, 175, 2024 | | 2024 |